<DOC>
	<DOCNO>NCT02059512</DOCNO>
	<brief_summary>The purpose study evaluate effect method administration autologous bone marrow mononuclear cell duration function aorto-coronary bypass graft surgical treatment coronary heart disease , assess degree effectiveness depend method transplantation ( intramyocardial , intracoronary ) .</brief_summary>
	<brief_title>Autologous Bone Marrow Mononuclear Cells Combined Treatment Coronary Heart Disease</brief_title>
	<detailed_description>Additional estimation safety : 1 . Assessment EuroScore II . 2 . The duration stay intensive care unit . 3 . Restoration cardiac rhythm end main stage operation ( defibrillation / self-recovery ) . 4 . The time extracorporeal circulation . 5 . Time anoxia . 6 . The amount blood loss drainage 1st day . 7 . The amount discharge second day . 8 . Troponin I 1 , 2 , 3 postoperative day . 9 . Postoperative complication ( hydrothorax , hydropericardium , arrhythmia ) . Predicting result treatment ( effect number parameter ) : 1 . Age . 2 . Gender . 3 . The body mass index . 4 . Diabetes . 5 . Smoking . 6 . Family history cardiovascular event . 7 . Duration ischemic heart disease . 8 . Serum total cholesterol ( + fraction ) . 9 . Leukocytosis CRP level ( initial level rate decrease postoperative period ) . 10 . The level creatinine . 11 . The presence / absence extracardiac arteriopathy . 12 . The intramyocardial intracoronary injection BM-MNCs . 13 . Assessment bone marrow : number nucleated cell , CD34 + , CD133 + .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>Men woman 18 80 year Patients angina pectoris IIIIV functional class Patients sign informed consent Intolerance heparin HES . Hypothyroidism hyperthyroidism . Associated pathology project lifespan limitation 3 year . infection diseases Simultaneous participation another study . Pregnancy . Severe mental disorder . Refusal patient participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>ischemic heart disease ,</keyword>
	<keyword>autologous bone marrow mononuclear cell</keyword>
	<keyword>coronary artery bypass grafting</keyword>
</DOC>